Nov 30 (Reuters) - Cns Pharmaceuticals Inc:
* CNS PHARMACEUTICALS ANNOUNCES PRICING OF $6.0 MILLION PUBLIC OFFERING AT A PREMIUM TO THE MARKET CLOSING PRICE
* PRICING OF A PUBLIC OFFERING OF 1.9 MILLION SHARES OF COMMON STOCK AND WARRANTS AT A COMBINED PRICE OF $3.175 PER SHARE Source text for Eikon: Further company coverage: